CMAJ August 28, 2007; 177 (5). doi:10.1503/cmaj.070013.
© 2007 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
Feasibility of self-collection of specimens for human papillomavirus testing in hard-to-reach women
Gina Ogilvie, MD MSc,
Mel Krajden, MD,
Juanita Maginley, RN,
Judy Isaac-Renton, MD,
Greg Hislop, MDCM MSc,
Ruth Elwood-Martin, MD,
Chris Sherlock, MB,
Darlene Taylor, BSN and
Michael Rekart, MD
From the British Columbia Centre for Disease Control (Ogilvie, Krajden, Maginley, Isaac-Renton, Taylor, Rekart); the British Columbia Cancer Agency (Hislop); the Department of Family Practice (Elwood-Martin), University of British Columbia; and Providence Health Care (Sherlock), Vancouver, BC
Correspondence to: Dr. Gina Ogilvie, Assistant Professor, University of British Columbia, Associate Director, Division of STI/HIV Prevention and Control, British Columbia Centre for Disease Control, 655 West 12th Ave., Vancouver BC V5Z 4R4; fax 604 775-0808; gina.ogilvie{at}bccdc.ca
To study the feasibility of self-collected specimens for testing human papillomavirus (HPV) status among hard-to-reach women, outreach nurses recruited women in women's centres, shelters and alleys in Vancouver's Downtown Eastside. Of the 151 participants for whom samples were available, 43 (28.5%) tested positive for high-risk HPV. Outreach nurses were able to recontact 81.4% of the participants who tested positive and referred them for further testing. About 14% (21/151) of participants had never received a Papanicolaou smear in British Columbia, as compared with 8.3% (608/7336) of women in the BC general population (p < 0.05). This difference suggests that self-collection of specimens for HPV testing is a feasible method to reach women who have not previously participated in cervical cancer screening programs.
Related Articles
-
Highlights of this issue
Can. Med. Assoc. J. 2007 177: 437.
[Full Text]
[PDF]
-
Dans ce numéro
Can. Med. Assoc. J. 2007 177: 437.
[Full Text]
[PDF]
-
Human papillomavirus vaccines launch a new era in cervical cancer prevention
- Meenakshi Dawar, MD MHSc, Shelley Deeks, MD MHSc, and Simon Dobson, MD
Can. Med. Assoc. J. 2007 177: 456-461.
[Full Text]
[PDF]
-
Patient information about HPV and the HPV vaccine
- Tavé van Zyl, Eric Wooltorton, MD MSc, and Noni MacDonald, MD MSc
Can. Med. Assoc. J. 2007 177: 462.
[Full Text]
[PDF]
-
Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection
- Marc Brisson, PhD, Nicolas Van de Velde, MSc, Philippe De Wals, MD PhD, and Marie-Claude Boily, PhD
Can. Med. Assoc. J. 2007 177: 464-468.
[Abstract]
[Full Text]
[PDF]
-
Human papillomavirus, vaccines and women's health: questions and cautions
- Abby Lippman, PhD, Ryan Melnychuk, PhD, Carolyn Shimmin, BJ, and Madeline Boscoe, RN DU
Can. Med. Assoc. J. 2007 177: 484-487.
[Full Text]
[PDF]
-
Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials
- Lisa Rambout, BScPhm, Laura Hopkins, MD MSc, Brian Hutton, MSc, and Dean Fergusson, PhD
Can. Med. Assoc. J. 2007 177: 469-479.
[Abstract]
[Full Text]
[PDF]